PLUS1
2.52
0.11 (4.56%)
0.11 (4.56%)
Upgrade to Real-Time
Premarket
| Volume | 12,611 |
|
|||||
| News | (1) | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Invitae Corporation | NVTA | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.11 | 4.56% | 2.52 | 07:56:32 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.41 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 83 | 12,611 | - | 1.83 - 30.28 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:56:33 | 90 | $ 2.51 | USD |
Period:
Draw Mode:
Invitae Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 592.87M | 235.27M | 207.58M | $ 460.45M | $ -432.50M | -1.89 | -0.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1.33M | 1.70% |
Invitae News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVTA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.01 | 3.32 | 2.37 | 2.64 | 9,742,406 | -0.49 | -16.28% |
| 1 Month | 3.11 | 4.20 | 2.37 | 3.24 | 10,084,806 | -0.59 | -18.97% |
| 3 Months | 2.53 | 9.00 | 1.83 | 4.70 | 19,388,135 | -0.01 | -0.4% |
| 6 Months | 7.83 | 9.18 | 1.83 | 4.52 | 13,654,374 | -5.31 | -67.82% |
| 1 Year | 30.00 | 30.28 | 1.83 | 6.85 | 9,145,450 | -27.48 | -91.6% |
| 3 Years | 19.27 | 61.59 | 1.83 | 17.29 | 5,205,090 | -16.75 | -86.92% |
| 5 Years | 8.95 | 61.59 | 1.83 | 17.21 | 3,614,870 | -6.43 | -71.84% |
Invitae Description
| Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. |
